Medical/Pharmaceuticals

Appealing Data of CARsgen Therapeutics' CAR-T (CT041) in Advanced Gastric Cancer Presented at ESMO

SHANGHAI, Sept. 19, 2021 /PRNewswire/ -- On September 19, 2021, CARsgen Therapeutics (stock code: 2171.HK) disclosed the latest progress of the investigator-initiated trial (IIT) of Claudin18.2 (CLDN18.2) CAR-T (CT041) for the treatment of digestive system tumors. Results of this trial have been ...

2021-09-20 08:24 7023

Illumina reaffirms commitment to the National Project of Bio Big Data in Korea

MELBOURNE, Australia, Sept. 20, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that the National Project of Bio Big Data in Korea has selected Illumina technology for the second pilot project in their effort to work towards establishing a national digital library on health and...

2021-09-20 07:00 4567

Qynapse Unveils Strategic Rebrand To Support Accelerated Growth And New Corporate Vision

BOSTON, Sept. 20, 2021 /PRNewswire/ -- Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, unveils a full rebrand including new logo and a complete website redesign, intended to better reflect the comp...

2021-09-20 06:00 2054

New Zealand's Cancer Organisations Warn Of COVID Pandemic-led Drop In Cancer Being Diagnosed And Treated

* Growing concern that people are reluctant to see their doctor about troubling symptoms during current uncertain period. This follows last year's lockdown which saw a decline in diagnosis of cancer across Aotearoa.[1]  * Around 9,000 New Zealanders die of cancer every year.[2]  * New campai...

2021-09-20 06:00 1666

CStone presents preliminary results from a phase Ib study of the anti-CTLA-4 monoclonal antibody (mAb) CS1002 in combination with the anti-PD-1 mAb CS1003 in patients with advanced solid tumors at ESMO 2021

SUZHOU, China, Sept. 19, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative cancer immunotherapies and precision medicines, today announced the preliminary results from t...

2021-09-19 09:00 3450

2021 CSCO | Henlius will Release Four Oral Presentations of Two Upcoming Commercial Products: Novel anti-PD-1 mAb Serplulimab and Bevacizumab Biosimilar

SHANGHAI, Sept. 18, 2021 /PRNewswire/ -- The 24th Annual Meeting of Chinese Society of Clinical Oncology (CSCO) will be held online and in-person from 25th to 29th September 2021. In this meeting, Henlius will release 4 study results of 2 products to be commercialized, the novel anti-PD-1 mAb ser...

2021-09-18 20:00 11476

Innovent Releases Interim Analysis Results of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma in the Phase 3 ORIENT-16 Study at ESMO Congress 2021

SAN FRANCISCO and SUZHOU, China, Sept. 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-09-18 08:00 14400

Innovent Releases Interim Analysis Results of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma in the Phase 3 ORIENT-15 Study at ESMO Congress 2021

SAN FRANCISCO and SUZHOU, China, Sept. 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dis...

2021-09-18 08:00 6677

Luye Pharma Becomes the Marketing Authorization Holder for Seroquel and Seroquel XR in Saudi Arabia

JEDDAH, Saudi Arabia, Sept. 17, 2021 /PRNewswire/ -- Luye Pharma Group has recently been granted official approval by the Saudi Food and Drug Authority to become the Marketing Authorization Holder (MAH) for Seroquel and Seroquel XR in Saudi Arabia. Meanwhile, the new localized packaging for Seroqu...

2021-09-17 22:16 1982

Lunit AI Applied to Clinical Trial for Drug Development for the First Time--Findings Presented at ESMO 2021

SEOUL, South Korea, Sept. 17, 2021 /PRNewswire/ -- A leading medical AI provider Lunit today announced that its AI for tissue analysis has been applied in a clinical trial for drug development, accurately predicting the patients' response to immunotherapy. Including this major finding, the compan...

2021-09-17 21:00 1408

#WeToo launches movement to bring leading businesses and individuals into the fight against child abuse

GENEVA and PARIS, Sept. 17, 2021 /PRNewswire/ -- #WeToo, the world's first global organisation to eradicate child abuse, launches today. It will bring together leading businesses and individuals to raise funds and awareness to help tackle the growing abuse of children worldwide. UNICEF and the W...

2021-09-17 20:40 2591

InnoCare and Keymed Jointly Announce Approval of Clinical Trial of CD20xCD3 Bispecific Antibody CM355

BEIJING, Sept. 17, 2021 /PRNewswire/ -- InnoCare Pharma (HKEX: 09969) and Keymed Biosciences (HKEX: 02162) jointly announced today that the Investigational New Drug (IND) of CM355, a CD20xCD3 bispecific antibody developed by a joint venture between the two companies called Tiannuojiancheng Pharm...

2021-09-17 20:00 4003

The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for First-Line Treatment of sqNSCLC Accepted by China's NMPA, Phase 3 MRCT Met its Primary Endpoint

SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the New Drug Application (NDA) of Serplulimab Injection (HLX10), a novel anti-PD-1 monoclonal antibody (mAb) independently developed by the company, in combination with carboplatin and albumin-bound ...

2021-09-17 20:00 4033

Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2021

HONG KONG, Sept. 17, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 20...

2021-09-17 19:00 18262

111, Inc. Announces Participation in the Cantor Virtual Global Healthcare Conference

SHANGHAI, Sept. 17, 2021 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced that Senior Vice President, Investor Relations and...

2021-09-17 19:00 3807

Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare

TOKYO, Sept. 17, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543), a global leader in medical technology, today celebrates its 100th anniversary. The company, based inTokyo, boasts over 25,000 associates worldwide, providing products and services to more than 160 countries and regions across...

2021-09-17 15:30 2968

Vieworks to Showcase its Complete Dental Detector Lineup at IDS 2021

ANYANG, South Korea, Sept. 17, 2021 /PRNewswire/ -- Vieworks, a global leader in the X-ray imaging industry, presents its complete dental detector lineups at the International Dental Show (IDS) 2021 (hall 11.2 P/R 28/29) from 22 to 25 September. IDS is the world's biggest trade fair for dentistry...

2021-09-17 15:00 1944

BioVaxys Cancer Vaccine Manufacturing Partner Bio Elpida Reaches Bioproduction Milestone

VANCOUVER, British Columbia, Sept. 17, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that cancer vaccine manufacturing partner Bio Elpida inLyon, France, has reached major milestones in the development of the bioproduction proce...

2021-09-17 15:00 4500

Innovent Releases Phase 2 Results of Pemigatinib in Chinese Patients with Advanced Cholangiocarcinoma at ESMO Congress 2021

SAN FRANCISCO and SUZHOU, China, Sept. 17, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-09-17 08:00 5272

Arctic Vision Announces Addition of Novel Mydriatic Drug MydCombi™ (ARVN004) to Eyenovia Commercialization Deal

SHANGHAI, Sept. 16, 2021 /PRNewswire/ -- Arctic Vision, a China-based biotech company focused on innovative ophthalmic therapies, announced today that it will expand its exclusive license agreement with Eyenovia, Inc. (NASDAQ: EYEN) to include a third asset, MydCombi™, for development and commerc...

2021-09-17 08:00 1260
1 ... 329330331332333334335 ... 573

Week's Top Stories